BackgroundTofacitinib is a novel, oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA).ObjectivesTo evaluate the malignancies that occurred in Japanese patients in the tofacitinib RA programme from the...
Published in last 50 years